1Sbarouni E,Georgiadou P,Kremastinos DT,et al. Ischemiamodified albumin:Is this marker of ischemia ready for prime timeUse? Hellenic J Cardiol,2008,49:260-266.
2Bali L,Cuisset T,Giorgi R,et al. Prognostic value of ischaemia-modified albumin in patients with non-ST-segment elevation acutecoronary syndromes. Arch Cardiovasc Dis,2008,101:645-651.
3Worster A,Devereaux PJ,Heels-Ansdell D,et al. Capability ofischemia modified albumin to predict serious cardiac outcomes inthe short term among patients with potential acute coronarysyndrome. CMAJ,2005,172:1685-1690.
4Aparci M,Kardesoglu E,Ozmen N,et al. Prognostic significanceof ischemia modified albumin in patients with acute coronarysyndrome. Coron Artery Dis,2007 ,18:367-373.
5Dusek J,St/6sek J,Tichy M,et al. Prognostic significance ofischemia modified albumin after percutaneous coronaryintervention. Clin Chim Acta,2006,367 :77-80.
6Quiles J,Roy D,Gaze D,et al. Relation of ischemia-modifiedalbumin (IMA) levels following elective angioplasty for stableangina pectoris to duration of balloon-induced myocardialischemia. Am J Cardiol,2003,92:322-324.
7Garrido IP,Roy D,Calvino R,et al. Comparison of ischemia-modified albumin levels in patients undergoing percutaneouscoronary intervention for unstable angina pectoris with versuswithout coronary collaterals. Am J Cardiol,2004,93:88-90.
